Caplin Point Laboratories (CAPLIPOINT) Share Price Falls 2.07% as Stock Trades at Rs 2,806.35
- September 25, 2026
- Posted by: Harsh Piplani
- Category: News
Caplin Point Laboratories Share Price declined today, with the stock at Rs 2,806.35, down 2.07% from the previous close of Rs 2,865.80. The company’s market capitalisation stands at Rs 21,217.14 crore, placing it in the Large Cap category. The session showed an intraday fall without any company-specific catalyst in the supplied data. The stock opened above the previous close, touched a day high of Rs 2,908.45, and ended at the day low of Rs 2,806.35. For readers tracking Caplin Point Laboratories Share Price Today, the verified figures show a clear price action event that is best read alongside fundamentals and peer context.
Turnover for the session was Rs 1.7 crore. That is a factual traded-value figure and should be read with the move, not as a cause. In Caplin Point Laboratories Stock News terms, today’s decline is notable because the stock closed at the lowest point of the session and remains a large company by market value. The next step is to place Caplin Point Laboratories Share Price against its operating and valuation profile.
Caplin Point Laboratories (CAPLIPOINT) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,806.35 |
| Previous Close | Rs 2,865.8 |
| Today's Move | -Rs 59.45 (-2.07%) |
| Open | Rs 2,883.05 |
| High | Rs 2,908.45 |
| Low | Rs 2,806.35 |
| Turnover | Rs 1.7 crore |
| Market Capitalisation | Rs 21,217.14 crore |
| Market Cap Category | Large Cap |
Caplin Point Laboratories Share Price Today closed at Rs 2,806.35 after falling Rs 59.45, or 2.07%, from the previous close. The stock opened at Rs 2,883.05, moved to a day high of Rs 2,908.45, and then finished at the day low. That sequence indicates that early strength was not sustained through the session.
The turnover of Rs 1.7 crore is a session-specific figure and does not explain the move on its own. For Caplin Point Laboratories Stock Falling Today searches, the confirmed record is straightforward: the share price declined by 2.07% and the close matched the low. With market capitalisation at Rs 21,217.14 crore, the move remains relevant for Caplin Point Laboratories Stock News and Caplin Point Laboratories Share Price News coverage.
Caplin Point Laboratories (CAPLIPOINT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 21,217.14 crore |
| P/E Ratio | 32.74x |
| P/B Ratio | 5.93x |
| ROE | 20.79% |
| ROCE | 24.97% |
| EPS | Rs 87.53 |
| Book Value Per Share | Rs 483.17 |
| Dividend Yield | 0.28% |
Caplin Point Laboratories Fundamental Analysis is shaped by a market capitalisation of Rs 21,217.14 crore, a P/E ratio of 32.74, a P/B ratio of 5.93, ROE of 20.79%, ROCE of 24.97%, EPS of Rs 87.53, book value of Rs 483.17 and dividend yield of 0.28%. These are the core figures behind Caplin Point Laboratories Share Price analysis beyond the day’s decline.
On valuation, the P/E ratio of 32.74 sits almost exactly on the industry median of 32.73 within the same industry benchmark set, while the P/B ratio of 5.93 is above the sector benchmark median of 2.95. Profitability metrics are stronger than the benchmark medians as well, with ROE of 20.79% compared with 11.7% and ROCE of 24.97% compared with 13.61%. EPS of Rs 87.53 shows earnings attributable to each share, book value of Rs 483.17 shows the accounting net worth behind each share, and dividend yield of 0.28% is the current reference payout metric. In Caplin Point Laboratories Stock Analysis terms, the supplied numbers point to solid profitability and a valuation that is close to the industry midpoint on earnings while remaining premium on book value.
For Caplin Point Laboratories Financial Results searches, the main takeaway is that profitability ratios are above the industry medians. That provides a fuller read of Caplin Point Laboratories Share Price Today than the single-day move alone.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 32.74x |
| Benchmark Median P/E | 32.73x |
| Benchmark Average P/E | 49.58x |
| Benchmark P/E Range | 3.48x to 757.76x |
| Company P/B Ratio | 5.93x |
| Benchmark Median P/B | 2.95x |
| Benchmark Average P/B | 4.37x |
| Company ROE | 20.79% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.7% |
| Company ROCE | 24.97% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 21,217.14 crore |
| Benchmark Median Market Cap | Rs 804.62 crore |
| Benchmark Average Market Cap | Rs 14,476.05 crore |
Caplin Point Laboratories operates in Healthcare within Pharmaceuticals & Drugs, and the supplied benchmark scope covers 199 companies from the same industry. The company’s P/E of 32.74 compares with an industry median of 32.73, an average of 49.58, a minimum of 3.48 and a maximum of 757.76 across 169 observations. That places Caplin Point Laboratories Share Price close to the benchmark midpoint on earnings.
On book value multiples, the P/B of 5.93 is above the industry median of 2.95 and the average of 4.37 across 198 observations. ROE of 20.79% is well above the industry median of 11.7%, and ROCE of 24.97% is above the median of 13.61%. The market capitalisation benchmark shows a median of Rs 804.62 crore and an average of Rs 14,476.05 crore across 199 companies, while Caplin Point Laboratories stands at Rs 21,217.14 crore. This is why Caplin Point Laboratories Share Price is best viewed within a wider Healthcare frame rather than in isolation.
For Caplin Point Laboratories Share Price Today, the sector comparison suggests a company with stronger-than-median profitability and a higher-than-median book multiple. That does not explain the day’s fall, but it does explain why the stock remains relevant to watch.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,47,475.97 | 36.76 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,54,763.56 | 87.25 | 14.45 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,423.19 | 86.07 | 20.91 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,16,658.07 | 26.08 | 4.37 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,11,484.47 | 33.65 | 3.23 | 11.83 | 16 |
Caplin Point Laboratories Share Price can be compared with listed peers on valuation, profitability and size. Sun Pharmaceutical Industries has a market cap of Rs 4,47,475.97 crore, P/E of 36.76, P/B of 5.14, ROE of 14.85% and ROCE of 19.11%. Divi’s Laboratories shows P/E of 87.25 and P/B of 14.45, while Torrent Pharmaceuticals is at P/E of 86.07 and P/B of 20.91. Zydus Lifesciences has a P/E of 26.08 and P/B of 4.37, and Cipla has a P/E of 33.65 and P/B of 3.23.
Against this peer set, Caplin Point Laboratories’ P/E of 32.74 sits below Sun Pharma, Divi’s Labs and Torrent Pharma, while remaining above Zydus Lifesciences. Its P/B of 5.93 is higher than Sun Pharma, Zydus Lifesciences and Cipla, but lower than Divi’s Labs and Torrent Pharma. On profitability, Caplin Point Laboratories’ ROE of 20.79% and ROCE of 24.97% compare favourably with Sun Pharma, Divi’s Labs, Zydus Lifesciences and Cipla on ROCE, while Torrent Pharma has the highest ROE in this peer list. For Caplin Point Laboratories Stock Analysis, this mix shows a company that is neither the cheapest nor the most richly valued peer, but one that combines solid profitability with a sizeable market cap.
Why Investors Are Watching Caplin Point Laboratories
- Caplin Point Laboratories Share Price fell 2.07% today to Rs 2,806.35 from Rs 2,865.80.
- The stock opened at Rs 2,883.05, reached Rs 2,908.45 and ended at Rs 2,806.35.
- Market capitalisation stands at Rs 21,217.14 crore, placing it in the Large Cap category.
- P/E is 32.74, P/B is 5.93, ROE is 20.79% and ROCE is 24.97%.
- Caplin Point Laboratories Share Price is above the industry benchmark median on ROE, ROCE and P/B.
About Caplin Point Laboratories
Caplin Point Laboratories is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data places the company within a benchmark set of 199 industry peers, which is useful for Caplin Point Laboratories Share Price analysis and for tracking Caplin Point Laboratories Stock News. Caplin Point Laboratories Share Price Today is best understood through market capitalisation, valuation, profitability and peer context.
Track Caplin Point Laboratories Share Price on Univest
Use Caplin Point Laboratories (CAPLIPOINT) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.
Track Caplin Point Laboratories Share Price on Univest for live price updates, key valuation ratios, shareholding pattern, 52-week levels and broader market insights. Univest also helps readers follow Caplin Point Laboratories Stock News, Caplin Point Laboratories Share Price Live and Caplin Point Laboratories Stock Analysis in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Caplin Point Laboratories Share Price fall today?
Ans. The supplied data confirms a same-day fall of 2.07% to Rs 2,806.35 from Rs 2,865.80, but it does not establish a company-specific catalyst. The article therefore treats it as a verified price event.
What is Caplin Point Laboratories Share Price today?
Ans. Caplin Point Laboratories Share Price today is Rs 2,806.35. It declined Rs 59.45 during the session and closed at the day’s low, after opening at Rs 2,883.05 and touching Rs 2,908.45.
What is Caplin Point Laboratories market capitalisation?
Ans. The company’s market capitalisation is Rs 21,217.14 crore. It is classified as a Large Cap in the supplied data, which makes the stock size materially larger than the industry median company in the benchmark set.
How does Caplin Point Laboratories compare on valuation?
Ans. Caplin Point Laboratories has a P/E of 32.74 and a P/B of 5.93. Its P/E is almost equal to the industry median of 32.73, while its P/B is above the industry median of 2.95.
What do Caplin Point Laboratories ROE and ROCE show?
Ans. ROE is 20.79% and ROCE is 24.97%. Both are above the industry medians of 11.7% and 13.61%, respectively, indicating profitability and capital efficiency that compare well with the benchmark sample.
What do EPS, book value and dividend yield mean for Caplin Point Laboratories?
Ans. EPS is Rs 87.53, book value is Rs 483.17 and dividend yield is 0.28%. EPS reflects earnings per share, book value reflects accounting net worth per share, and dividend yield shows the payout reference at the current price.
How does Caplin Point Laboratories compare with sector peers?
Ans. Caplin Point Laboratories’ P/E is below Divi’s Labs and Torrent Pharma, above Zydus Lifesciences, and near Cipla. Its ROE and ROCE are also stronger than several peers in the supplied comparison set.
What sector does Caplin Point Laboratories belong to?
Ans. Caplin Point Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The benchmark set used in the article covers 199 companies from the same industry, allowing direct comparison.
Where can investors track Caplin Point Laboratories Share Price?
Ans. Investors can track Caplin Point Laboratories Share Price on Univest, where live price updates, key ratios, shareholding pattern, 52-week levels and market insights are presented in one stock page. The previous close was Rs 2,865.8.
